{
    "eid": "2-s2.0-85076432204",
    "title": "Clinical and subclinical acute kidney injury in multidrug-resistant septic patients treated with colistimethate sodium: Incidence and clinical outcomes",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "clinical AKI",
        "colistimethate sodium",
        "subclinical acute kidney injury (AKI)",
        "urinary liver-type fatty-acid-binding protein",
        "urinary neutrophil gelatinase-associated lipocalin"
    ],
    "authors": [
        "Theerachai Thammathiwat",
        "Khajohn Tiranathanagul",
        "Nattachai Srisawat",
        "Paweena Susantitaphong",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong"
    ],
    "citedby-count": 6,
    "ref-count": 23,
    "ref-list": [
        "Colistin- and polymyxin-induced nephrotoxicity: focus on literature utilizing the RIFLE classification scheme of acute kidney injury",
        "Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients",
        "Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center",
        "Attributable risk and time course of Colistin-associated acute kidney injury",
        "The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies",
        "Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin",
        "The role of urine neutrophil Gelatinase-associated Lipocalin as a predictive biomarker for colistin-induced acute kidney injury [abstract]",
        "Evaluation of renal toxicity of colistin therapy with neutrophil gelatinase-associated lipocalin: a biomarker of renal tubular damage",
        "Monitoring of effectiveness and safety of colistin for therapy in resistant gram-negative bacterial infections in hospitalized patients at Siriraj hospital",
        "Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice",
        "Biomarkers in nephrology: core curriculum 2013",
        "Urinary liver type-fatty acid binding protein and plasma cystatin C as early predictors of contrast induced acute kidney injury",
        "Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI)",
        "Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein",
        "Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis",
        "Mild elevation of urinary biomarkers in prerenal acute kidney injury",
        "Comparison of three early biomarkers for acute kidney injury after cardiac surgery under cardiopulmonary bypass",
        "Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation",
        "Nephrotoxicity of high and conventional dosing regimens of colistin: a randomized clinical trial",
        "Pharmacokinetic/toxicodynamic analysis of colistin-associated acute kidney injury in critically ill patients",
        "Risk factors of colistin safety according to administration routes: intravenous and aerosolized colistin",
        "Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial",
        "Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}